Musculoskeletal Pain

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

DP
Daehwa PharmaceuticalKorea - Gangwon
1 program
1
DHP2306R1Phase 11 trial
Active Trials
NCT06395155Completed54Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Daehwa PharmaceuticalDHP2306R1

Clinical Trials (1)

Total enrollment: 54 patients across 1 trials

A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers

Start: Oct 2023Est. completion: Dec 202354 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space